Clinical Trial Update: Mechanisms of Smell Improvement With Dupilumab. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on the mechanisms by which dupilumab may improve sense of smell in chronic rhinosinusitis with nasal polyps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 4 | Status: COMPLETED